Actively Recruiting
Indicators Affecting PVT Recanalization
Led by Shanghai Zhongshan Hospital · Updated on 2026-03-16
1500
Participants Needed
1
Research Sites
626 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a retrospective-prospective study conducted at Zhongshan Hospital, Fudan University, to explore portal vein thrombosis (PVT) in patients with cirrhosis and gastroesophageal varices (GEV). It aimed to provide insights into the diagnosis, follow-up, and factors influencing PVT recanalization, to help patients, families, and healthcare providers understand the disease and related clinical management.
CONDITIONS
Official Title
Indicators Affecting PVT Recanalization
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with cirrhosis and confirmed gastroesophageal varices by endoscopy
- Diagnosed with portal vein thrombosis (PVT) by CT angiography at admission
You will not qualify if you...
- Patients with hepatocellular carcinoma
- Patients with extrahepatic malignancies
- History of liver transplantation or transjugular intrahepatic portosystemic shunt (TIPS)
- Lack of information regarding anticoagulation therapy
- Presence of cavernous transformation of the portal vein (CTPV)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
S
Siyu Jiang, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here